v3.25.2
SCHEDULE OF NON CONTROLLING INTEREST (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]          
Net loss attributable to the non-controlling interest $ (13,324) $ (13,324)
Subsidiaries [Member]          
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]          
Net loss Subsidiary       (27,191)
Net loss attributable to the non-controlling interest       13,324
Net loss affecting Bioxytran       (13,867)
Accumulated deficit       (3,955,108)
Accumulated deficit attributable to the non-controlling interest       855,160
Accumulated deficit affecting Bioxytran       (3,099,948)
Net equity non-controlling interest       $ (694,210)